Interstitial Cystitis Therapeutics - Pipeline Assessment

and Market Forecasts to 2019

On 18thNovember 2014

Summary
The industry analysis specialist, has released its new report, Interstitial Cystitis Therapeutics Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of
information and analysis on the global Interstitial Cystitis Therapeutics market. The report
identifies the key trends shaping and driving the global Interstitial Cystitis Therapeutics market.
The report also provides insights on the prevalent competitive landscape and the emerging
players expected to significantly alter the market positioning of the current market leaders.
Most importantly, the report provides valuable insights on the pipeline products within the
global Interstitial Cystitis Therapeutics sector. This report is built using data and information
sourced from proprietary databases, primary and secondary research and in-house analysis by
GlobalDatas team of industry experts.

You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-interstitial-cystitis-therapeutics-pipeline-assessment-and-marketforecasts-135249

Scope
The report provides information on the key drivers and challenges of the Interstitial Cystitis
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Interstitial
Cystitis Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends by seven key markets. Pipeline candidates fall under major
therapeutic classes.
- Analysis of the current and future competition in the seven key countries Interstitial Cystitis
Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet
needs and the implications for the Interstitial Cystitis Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Interstitial Cystitis Therapeutics
market

Reasons to buy
The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline
products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global
Interstitial Cystitis Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies,
market segments and companies likely to impact the global Interstitial Cystitis Therapeutics
market in future.
- Formulate effective sales and marketing strategies by understanding the competitive
landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective
counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments
that present maximum opportunities for consolidations, investments and strategic
partnerships.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

- Whats the next big thing in the global Interstitial Cystitis Therapeutics market landscape?
Identify, understand and capitalize.

Other industries we cover:

Advertising and Media

Automotive and Parts
Consumer Goods
Healthcare and Medical
Finance and Banking
Food and Beverages
Travel and Tourism
Textiles and Clothing
SWOT Analysis

Discounts on Market Research Reports till 31st December, 2014

For more inquiries, contact at +91 - 998 729 5242 /
contact@jsbmarketresearch.com

Table of Content
2 Interstitial Cystitis Therapeutics - Introduction
2.1 Overview
2.2 Epidemiology
2.3 Etiology
2.4 Symptoms
2.5 Diagnosis
2.5.1 Medical History
2.5.2 Physical Examination
2.5.3 Laboratory Tests
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

2.5.4 Other Investigations

2.6 Pathophysiology
2.7 Treatment and Management Pattern
2.7.1 Oral Pharmacological Approach
2.7.2 Intravesical Therapy
2.7.3 Transcutaneous Electrical Nerve Stimulation
2.7.4 Surgery
2.8 GlobalData Pipeline Report Guidance
3 Interstitial Cystitis Therapeutics - Market Characterization
3.1 Interstitial Cystitis Therapeutics Market Size (2006-2011) - Global
3.2 Interstitial Cystitis Therapeutics Market Forecast (2011-2019) - Global
3.3 Interstitial Cystitis Therapeutics Market Size (2006-2011) - The US
3.4 Interstitial Cystitis Therapeutics Market Forecast (2011-2019) - The US
3.5 Interstitial Cystitis Therapeutics Market Size (2006-2011) - France
3.6 Interstitial Cystitis Therapeutics Market Forecast (2011-2019) - France
3.7 Interstitial Cystitis Therapeutics Market Size (2006-2011) - Germany
3.8 Interstitial Cystitis Therapeutics Market Forecast (2011-2019) - Germany
3.9 Interstitial Cystitis Therapeutics Market Size (2006-2011) - Italy
3.10 Interstitial Cystitis Therapeutics Market Forecast (2011-2019) - Italy
3.11 Interstitial Cystitis Therapeutics Market Size (2006-2011) - Spain
3.12 Interstitial Cystitis Therapeutics Market Forecast (2011-2019) - Spain
3.13 Interstitial Cystitis Therapeutics Market Size (2006-2011) - The UK
3.14 Interstitial Cystitis Therapeutics Market Forecast (2011-2019) - The UK
3.15 Interstitial Cystitis Therapeutics Market Size (2006-2011) - Japan
3.16 Interstitial Cystitis Therapeutics Market Forecast (2011-2019) - Japan
3.17 Drivers and Barriers for the Interstitial Cystitis Therapeutics Market
3.17.1 Drivers for the Interstitial Cystitis Therapeutics Market
3.17.2 Barriers for the Interstitial Cystitis Therapeutics Market
3.18 Opportunity and Unmet Need
3.19 Key Takeaway
4 Interstitial Cystitis Therapeutics - Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profile for Major Marketed Products in the Interstitial Cystitis Therapeutics Market
4.3.1 Elmiron
4.3.2 Rimso-50 (dimethyl sulfoxide)
4.3.3 Tricyclic Antidepressants
4.3.4 Antihistamines
4.4 Key Takeaway
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

5 Interstitial Cystitis Therapeutics - Pipeline Assessment

5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Interstitial Cystitis - Pipeline Analysis by Phase of Development
5.3.1 Interstitial Cystitis- Phase III Pipeline
5.3.2 Interstitial Cystitis- Phase II Pipeline
5.3.3 Interstitial Cystitis- Phase I Pipeline
5.3.4 Interstitial Cystitis - Preclinical Pipeline
5.4 Interstitial Cystitis- Pipeline by Mechanism of Action
5.5 Technology Trends Analytical Framework
5.6 Pipeline Molecule Profile
5.6.1 Humira (adalimumab)
5.7 Key Takeaway
6 Interstitial Cystitis Therapeutics - Clinical Trials Mapping
6.1 Clinical Trials by Region and Country
6.2 Clinical Trials by Phase of Clinical Development
6.3 Clinical Trials by Trial Status
6.4 Clinical Trials by Sponsors
6.5 Top Companies Participating in Interstitial Cystitis Clinical Trials
7 Interstitial Cystitis Therapeutics - Strategic Assessment
7.1 Key Events Impacting the Future Market
7.2 Future Market Competition Scenario
8 Interstitial Cystitis Therapeutics - Future Players
8.1 Introduction
8.2 Company Profiles
8.2.1 Abbott Laboratories
8.3 Details of Other Companies in the Pipeline
8.4 Key Takeaway
9 Interstitial Cystitis Therapeutics - Licensing and Partnership Deals
10 Interstitial Cystitis Therapeutics - Appendix
10.1 Definitions
10.2 Acronyms
10.3 Research Methodology
10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Forecasting
10.3.4 Primary Research
10.3.5 Expert Panel Validation
10.4 Contact Us
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

10.5 Disclaimer
10.6 Bibliography
List Of Tables
Table 1: Interstitial Cystitis Therapeutics- Treatment Options (Oral Drugs)
Table 2: Interstitial Cystitis Therapeutics- Other Treatment Options
Table 3: Interstitial Cystitis Therapeutics Market, Global, Revenue ($m), 2006-2011
Table 4: Interstitial Cystitis Therapeutics Market, Global, Forecast ($m), 2011-2019
Table 5: Interstitial Cystitis Therapeutics Market, The US, Revenue ($m), 2006-2011
Table 6: Interstitial Cystitis Therapeutics Market, The US, Forecast ($m), 2011-2019
Table 7: Interstitial Cystitis Therapeutics Market, France, Revenue ($m), 2006-2011
Table 8: Interstitial Cystitis Therapeutics Market, France, Forecast ($m), 2011-2019
Table 9: Interstitial Cystitis Therapeutics Market, Germany, Revenue ($m), 2006-2011
Table 10: Interstitial Cystitis Therapeutics Market, Germany, Forecast ($m), 2011-2019
Table 11: Interstitial Cystitis Therapeutics Market, Italy, Revenue ($m), 2006-2011
Table 12: Interstitial Cystitis Therapeutics Market, Italy, Forecast ($m), 2011-2019
Table 13: Interstitial Cystitis Therapeutics Market, Spain, Revenue ($m), 2006-2011
Table 14: Interstitial Cystitis Therapeutics Market, Spain, Forecast ($m), 2011-2019
Table 15: Interstitial Cystitis Therapeutics Market, The UK, Revenue ($m), 2006-2011
Table 16: Interstitial Cystitis Therapeutics Market, The UK, Forecast ($m), 2011-2019
Table 17: Interstitial Cystitis Therapeutics Market, Japan, Revenue ($m), 2006-2011
Table 18: Interstitial Cystitis Therapeutics Market, Japan, Forecast ($m), 2011-2019
Table 19: Interstitial Cystitis Therapeutics - Phase III Clinical Pipeline, 2011
Table 20: Interstitial Cystitis Therapeutics - Phase II Clinical Pipeline, 2011
Table 21: Interstitial Cystitis Therapeutics - Phase I Clinical Pipeline, 2011
Table 22: Interstitial Cystitis Therapeutics - Pre-Clinical Pipeline, 2011
Table 23: Interstitial Cystitis Therapeutics, Global, Clinical Trials, 2011
Table 24: Interstitial Cystitis Therapeutics, Global, Clinical Trials by Phase, 2011
Table 25: Interstitial Cystitis Therapeutics, Global, Clinical Trials by Status of Development, 2011
Table 26: Interstitial Cystitis Therapeutics, Global, Overall Sponsors, 2011
Table 27: Interstitial Cystitis Therapeutics, Global, Prominent Sponsors, 2011
Table 28: Interstitial Cystitis Therapeutics,st Global, Top 10 Companies by Phase, 2011
Table 29: Abbott Laboratories - Interstitial Cystitis Pipeline, 2011
Table 30: Description of Other Companies in the Pipeline, 2011
Table 31: Interstitial Cystitis Therapeutics, Global, Deals, 2011
List Of Figures
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Figure 1: Interstitial Cystitis - Impact on Quality of Life

Figure 2: Interstitial Cystitis - Possible Causes
Figure 3: Interstitial Cystitis - Diagnosis Flow and List of Some Confusable Diseases
Figure 4: Interstitial Cystitis - Pathophysiology
Figure 5: Interstitial Cystitis - Oral Pharmacological Approach of Treatment
Figure 6: Interstitial Cystitis - Treatment Algorithm
Figure 7: Interstitial Cystitis Therapeutics Market, Global, Revenue ($m), 2006-2011
Figure 8: Interstitial Cystitis Therapeutics Market, Global, Forecast ($m), 2011-2019
Figure 9: Interstitial Cystitis Therapeutics Market, The US, Revenue ($m), 2006-2011
Figure 10: Interstitial Cystitis Therapeutics Market, The US, Forecast ($m), 2011-2019
Figure 11: Interstitial Cystitis Therapeutics Market, France, Revenue ($m), 2006-2011
Figure 12: Interstitial Cystitis Therapeutics Market, France, Forecast ($m), 2011-2019
Figure 13: Interstitial Cystitis Therapeutics Market, Germany , Revenue ($m), 2006-2011
Figure 14: Interstitial Cystitis Therapeutics Market, Germany, Forecast ($m), 2011-2019
Figure 15: Interstitial Cystitis Therapeutics Market, Italy, Revenue ($m), 2006-2011
Figure 16: Interstitial Cystitis Therapeutics Market, Italy, Forecast ($m), 2011-2019
Figure 17: Interstitial Cystitis Therapeutics Market, Spain, Revenue ($m), 2006-2011
Figure 18: Interstitial Cystitis Therapeutics Market, Spain, Forecast ($m), 2011-2019
Figure 19: Interstitial Cystitis Therapeutics Market, The UK, Revenue ($m), 2006-2011
Figure 20: Interstitial Cystitis Therapeutics Market, The UK, Forecast ($m), 2011-2019
Figure 21: Interstitial Cystitis Therapeutics Market, Japan, Revenue ($m), 2006-2011
Figure 22: Interstitial Cystitis Therapeutics Market, Japan, Forecast ($m), 2011-2019
Figure 23: Opportunity and Unmet Need in the Interstitial Cystitis Therapeutics Market, 2011
Figure 24: Strategic Competitor Assessment of the Marketed Products in Interstitial Cystitis
Therapeutics, 2011
Figure 25: Interstitial Cystitis - Clinical Pipeline by Phase of Development (%), 2011
Figure 26: Interstitial Cystitis Therapeutics, Clinical Pipeline by Mechanism of Action (%), 2011
Figure 27: Technology Trends Analytics Framework, 2011
Figure 28: Technology Trends Analytics Framework - Description, 2011
Figure 29: Interstitial Cystitis Therapeutics, Global, Clinical Trials by Country, 2011
Figure 30: Interstitial Cystitis Therapeutics, Global, Clinical Trials by Phase (%), 2011
Figure 31: Interstitial Cystitis Therapeutics, Global, Clinical Trials by Status of Development (%),
2011
Figure 32: Interstitial Cystitis Therapeutics, Global, Overall Sponsors (%), 2011
Figure 33: Interstitial Cystitis Therapeutics, Global, Prominent Sponsors (%), 2011
Figure 34: Interstitial Cystitis Therapeutics, Global, Top Companies by Phase, 2011
Figure 35: Interstitial Cystitis Therapeutics Market, Drivers and Barriers, 2011
Figure 36: Implications for Future Market Competition in the Interstitial Cystitis Therapeutics
Market, 2011
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Figure 37: Interstitial Cystitis Market, Clinical Pipeline by Company, 2011

Figure 38: GlobalData Market Forecasting Model

Report Price:
Licence Type

Price

PDF

$ 3995

Site Licence

$ 7990

Enterprise Wide Licence

$ 11985

Related Reports:
Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018
Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Hepatic Encephalopathy - Pipeline Assessment and Market Forecasts to 2019
Skin and Skin Structure Infections (SSSI) Therapeutics - Pipeline Assessment and Market Forecasts to
2019
Gauchers Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Sarcoidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Pompe Disease (GAA Deficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Cushings Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Amyloidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Addisons Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics - Pipeline Assessment and
Market Forecasts to 2019

You can order this report by calling on +91 - 998 7295 242 or mail us
your contact details at contact@jsbmarketresearch.com

About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along
with providing in-depth analysis though reports, JSB market research also provides regular
updates of the market though newsletters. Our reports are a well-researched work of market
researchers with an extensive knowledge and a good level of market experience.

To know more on Interstitial Cystitis Therapeutics - Pipeline Assessment and

Market Forecasts to 2019
http://www.jsbmarketresearch.com/healthcare-medical/r-interstitial-cystitistherapeutics-pipeline-assessment-and-market-forecasts-135249

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/